ArticleCureus2026

Triple-Dose Furmonertinib for Leptomeningeal Metastases in Advanced Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report.

Hong Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.